MicroPort CardioFlow Medtech Corporation (HKG:2160)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.8700
-0.0100 (-1.14%)
Jun 6, 2025, 3:59 PM HKT

MicroPort CardioFlow Medtech Company Description

MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally.

It engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valvular heart diseases, as well as properties management.

It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set, Angelguide tip-preshaped super stiff guidewire, mitral, tricuspid, and surgical accessories, as well as procedural accessories.

The company also provides technical consultation and technical services for medical devices clinical trial.

MicroPort CardioFlow Medtech Corporation was founded in 2009 and is headquartered in Shanghai, China.

MicroPort CardioFlow Medtech Corporation
Country Cayman Islands
Founded 2009
Industry Medical Devices
Sector Healthcare
Employees 430
CEO Ruinian Zhang

Contact Details

Address:
No. 1661 Zhangdong Road
Shanghai, 201203
China
Phone 86 21 3895 4600
Website cardioflowmedtech.com

Stock Details

Ticker Symbol 2160
Exchange Hong Kong Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number KYG6082P1054
SIC Code 3841

Key Executives

Name Position
Luying Yan Vice President and Executive Director
Liang Zhao Executive Director and First Vice President of Total Solutions
Ruinian Zhang President, GM and Executive Director
Xiangmei Li Joint Company Secretary
Lok Yee Chan A.C.I.S., A.C.S. Joint Company Secretary